TRDA: Entrada Therapeutics Inc
TRDA exchange rate has changed by 1.66% for today. During the day, the instrument was traded at a low of 10.7701 and at a high of 11.4900.
Follow Entrada Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
TRDA News
- Entrada Therapeutics, Inc. (TRDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Capricor Therapeutics Stock: A High Risk/High Reward Name (NASDAQ:CAPR)
- Entrada reports progress on DMD treatments, shares clinical timeline
- TD Cowen analyst highlights 10+ potential biotech catalysts for 2026
- Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
- Entrada: Soft Q3 Earnings, But Builds Momentum Toward 2026 Readouts (NASDAQ:TRDA)
- Entrada Therapeutics earnings missed by $0.07, revenue fell short of estimates
- Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates
- Bristol Myers Squibb (BMY) Q3 Earnings and Revenues Surpass Estimates
- Janux Therapeutics (JANX) Moves 8.8% Higher: Will This Strength Last?
- 3 Best Stocks to Buy Now, 10/24/2025, According to Top Analysts - TipRanks.com
- Entrada Therapeutics, Inc. (TRDA) Discusses on Home with HCW Call (Transcript)
- Goldman Sachs initiates coverage on Entrada Therapeutics stock with Early-Stage Biotech rating
- Tracking Baker Brothers Portfolio – Q2 2025 Update
- Entrada awards $100,000 in grants to Duchenne muscular dystrophy groups
- Roth/MKM lowers Entrada Therapeutics stock price target to $17 from $21
- Entrada (TRDA) Q2 Revenue Drops 98%
- Entrada Therapeutics August 2025 slides: advancing four clinical-stage programs
- Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Lags Revenue Estimates
- Entrada Therapeutics earnings missed by $0.22, revenue fell short of estimates
- Entrada Therapeutics (TRDA) Soars 5.6%: Is Further Upside Left in the Stock?
- Entrada therapeutics (TRDA) director Parmar sells $202k in stock
- 5am Ventures v sells Entrada Therapeutics (TRDA) stock for $202k
- Entrada Therapeutics (TRDA) 10% owners sell $866k in stock
Frequently Asked Questions
What is TRDA stock price today?
Entrada Therapeutics Inc stock is priced at 11.0000 today. It trades within 10.7701 - 11.4900, yesterday's close was 10.8200, and trading volume reached 950. The live price chart of TRDA shows these updates.
Does Entrada Therapeutics Inc stock pay dividends?
Entrada Therapeutics Inc is currently valued at 11.0000. Dividend policy depends on the company, while investors also watch 57.82% and USD. View the chart live to track TRDA movements.
How to buy TRDA stock?
You can buy Entrada Therapeutics Inc shares at the current price of 11.0000. Orders are usually placed near 11.0000 or 11.0030, while 950 and 1.29% show market activity. Follow TRDA updates on the live chart today.
How to invest into TRDA stock?
Investing in Entrada Therapeutics Inc involves considering the yearly range 6.0901 - 11.5500 and current price 11.0000. Many compare 7.32% and 57.82% before placing orders at 11.0000 or 11.0030. Explore the TRDA price chart live with daily changes.
What are Entrada Therapeutics Inc stock highest prices?
The highest price of Entrada Therapeutics Inc in the past year was 11.5500. Within 6.0901 - 11.5500, the stock fluctuated notably, and comparing with 10.8200 helps spot resistance levels. Track Entrada Therapeutics Inc performance using the live chart.
What are Entrada Therapeutics Inc stock lowest prices?
The lowest price of Entrada Therapeutics Inc (TRDA) over the year was 6.0901. Comparing it with the current 11.0000 and 6.0901 - 11.5500 shows potential long-term entry points. Watch TRDA moves on the chart live for more details.
When did TRDA stock split?
Entrada Therapeutics Inc has gone through stock splits historically. These changes are visible in , 10.8200, and 57.82% after corporate actions.
- Previous Close
- 10.8200
- Open
- 10.8600
- Bid
- 11.0000
- Ask
- 11.0030
- Low
- 10.7701
- High
- 11.4900
- Volume
- 950
- Daily Change
- 1.66%
- Month Change
- 7.32%
- 6 Months Change
- 57.82%
- Year Change
- 57.82%
- Act
- Fcst
- Prev